TNC and systemic sclerosis: In an initial analysis (Cohort 3, Table 2), serum tenascin-C levels were significantly elevated in SSc patients compared with healthy controls (mean, 71 ng ml−1, interquartile range 51.7–92.5 versus 37 ng ml−1, interquartile range 29–73; Fig. 1e).